- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
August 30th, 2005
Nanotechnology has received as much media attention (as) any other science sector since the space race of the 1960s. This hype has attracted large sums of 'reactionary' public and venture capital funding, and has brought in its wake tremendous pressure on market participants to deliver results.
The onus is now on participants in the nanobiotechnology applications sector to incorporate extensively researched technologies into commercially viable products.
|Related News Press|
Harris & Harris Group Sponsors NYC American Heart Association's Health Sciences Innovation Investment Forum: Co-founder of Harris & Harris Group Portfolio Company TARA Biosystems to Speak About the Value of Tissue Engineering Technology April 21st, 2015
Long Island Capital Alliance Announces Participants for Brookhaven National Laboratory Technology Transfer Capital Forum on May 8: Keynote Speaker Dr. Doon Gibbs, Director of Brookhaven National Laboratory April 16th, 2015
Graphenea embarks on a new era April 16th, 2015
Graphenea celebrates fifth anniversary April 27th, 2015